Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Kobold, Sebastian ^a,b   Tams, Sinje ^a   Luetkens, Tim ^a   Cao, Yanran ^a   Sezer, Orhan ^a   Bartels, Britta Marlen ^a   Reinhard, Henrike ^a   Templin, Julia ^a   Bartels, Katrin ^a   Hildebrandt, York ^a   Lajmi, Nesrine ^a   Marx, Andreas ^a   Haag, Friedrich ^a   Bokemeyer, Carsten ^a   Krger, Nicolaus ^a   Atanackovic, Djordje ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; TRANSCRIPTION FACTOR SOX2; IMMUNOGLOBULIN G; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; BONE MARROW; CANCER CHEMOTHERAPY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PLASMA CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ALLOTRANSPLANTATION; ANTIBODY SPECIFICITY; BLOOD; CHEMISTRY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; PROGNOSIS; TUMOR CELL LINE;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; CELL LINE, TUMOR; EPITOPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; MULTIPLE MYELOMA; PROGNOSIS; SOXB1 TRANSCRIPTION FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855170506     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/302145     Document Type: Article

References (26)

1. Episkopou V., SOX2 functions in adult neural stem cells Trends in Neurosciences 2005 28 5 219 221 (Pubitemid 41556906)
2. Dhodapkar M. V., Dhodapkar K. M., Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges Cancer Immunology, Immunotherapy 2011 60 3 413 418
3. Bass A. J., Watanabe H., Mermel C. H., Yu S., Perner S., Verhaak R. G., Kim S. Y., Wardwell L., Tamayo P., Gat-Viks I., Ramos A. H., Woo M. S., Weir B. A., Getz G., Beroukhim R., O'Kelly M., Dutt A., Rozenblatt-Rosen O., Dziunycz P., Komisarof J., Chirieac L. R., Lafargue C. J., Scheble V., Wilbertz T., Ma C., Rao S., Nakagawa H., Stairs D. B., Lin L., Giordano T. J., Wagner P., Minna J. D., Gazdar A. F., Zhu C. Q., Brose M. S., Cecconello I., Jr U. R., Marie S. K., Dahl O., Shivdasani R. A., Tsao M. S., Rubin M. A., Wong K. K., Regev A., Hahn W. C., Beer D. G., Rustgi A. K., Meyerson M., SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Nature Genetics 2009 41 11 1238 1242
4. Lengerke C., Fehm T., Kurth R., Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma BMC Cancer 2011 11 42
5. Titulaer M. J., Klooster R., Potman M., Sabater L., Graus F., Hegeman I. M., Thijssen P. E., Wirtz P. W., Twijnstra A., Sillevis Smitt P. A. E., van der Maarel S., Verschuuren J. J. G. M., SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival Journal of Clinical Oncology 2009 27 26 4260 4267
6. Spisek R., Kukreja A., Chen L. C., Matthews P., Mazumder A., Vesole D., Jagannath S., Zebroski H. A., Simpson A. J. G., Ritter G., Durie B., Crowley J., Shaughnessy J. D., Scanlan M. J., Gure A. O., Barlogie B., Dhodapkar M. V., Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy Journal of Experimental Medicine 2007 204 4 831 840 (Pubitemid 46631612)
7. Berenson J. R., Anderson K. C., Audell R. A., Boccia R. V., Coleman M., Dimopoulos M. A., Drake M. T., Fonseca R., Harousseau J. L., Joshua D., Lonial S., Niesvizky R., Palumbo A., Roodman G. D., San-Miguel J. F., Singhal S., Weber D. M., Zangari M., Wirtschafter E., Yellin O., Kyle R. A., Monoclonal gammopathy of undetermined significance: a consensus statement British Journal of Haematology 2010 150 1 28 38
8. Dhodapkar M. V., Bolejack V., Shaughnessy J., Role of T-cell immunity to embryonal stem (ES) cell antigen SOX2 in the progression of myeloma Journal of Clinical Oncology 2009 27 15, article 8522
9. Bellucci R., Alyea E. P., Chiaretti S., Wu C. J., Zorn E., Weller E., Wu B., Canning C., Schlossman R., Munshi N. C., Anderson K. C., Ritz J., Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor Blood 2005 105 10 3945 3950 (Pubitemid 40656141)
10. Bellucci R., Wu C. J., Chiaretti S., Weller E., Davies F. E., Alyea E. P., Dranoff G., Anderson K. C., Munshi N. C., Ritz J., Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens Blood 2004 103 2 656 663 (Pubitemid 38140101)
11. Atanackovic A. D., Luetkens T., Hildebrandt Y., Arfsten J., Bartels K., Horn C., Stahl T., Cao Y., Zander A. R., Bokemeyer C., Krger N., Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma Clinical Cancer Research 2009 15 4 1343 1352
12. Atanackovic D., Arfsten J., Cao Y., Gnjatic S., Schnieders F., Bartels K., Schilling G., Faltz C., Wolschke C., Dierlamm J., Ritter G., Eiermann T., Hossfeld D. K., Zander A. R., Jungbluth A. A., Old L. J., Bokemeyer C., Krger N., Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation Blood 2007 109 3 1103 1112 (Pubitemid 46220657)
13. Larsen J. E., Lund O., Nielsen M., Improved method for predicting linear B-cell epitopes Immunome Research 2006 2 2
14. Gre A. O., Stockert E., Scanlan M. J., Keresztes R. S., Jger D., Altorki N. K., Old L. J., Chen Y. T., Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer Proceedings of the National Academy of Sciences of the United States of America 2000 97 8 4198 4203 (Pubitemid 30226110)
15. Uozaki H., Barua R. R., Minhua S., Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancer International Journal of Clinical and Experimental Pathology 2011 4 3 320 340
16. Holmberg J., He X., Peredo I., Orrego A., Hesselager G., Ericsson C., Hovatta O., Oba-Shinjo S. M., Marie S. K. N., Nistér M., Muhr J., Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma PLoS ONE 2011 6 3, article e18454
17. Preuss K. D., Zwick C., Bormann C., Neumann F., Pfreundschuh M., Analysis of the B-cell repertoire against antigens expressed by human neoplasms Immunological Reviews 2002 188 43 50 (Pubitemid 35398864)
18. Schmitz M., Temme A., Senner V., Ebner R., Schwind S., Stevanovic S., Wehner R., Schackert G., Schackert H. K., Fussel M., Bachmann M., Rieber E. P., Weigle B., Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy British Journal of Cancer 2007 96 8 1293 1301 (Pubitemid 46625072)
19. Lukk M., Kapushesky M., Nikkil J., Parkinson H., Goncalves A., Huber W., Ukkonen E., Brazma A., A global map of human gene expression Nature Biotechnology 2010 28 4 322 324
20. Gutiérrez N. C., Ocio E. M., de las Rivas J., Maiso P., Delgado M., Fermin E., Arcos M. J., Snchez M. L., Hernndez J. M., Miguel J. F. S., Gene expression profiling of B lymphocytes and plasma cells from Waldenstrm's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals Leukemia 2007 21 3 541 549
21. Bellucci R., Oertelt S., Gallagher M., Li S., Zorn E., Weller E., Porcheray F., Alyea E. P., Soiffer R. J., Munshi N. C., Gershwin M. E., Ritz J., Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis Blood 2007 109 5 2001 2007 (Pubitemid 46348199)
22. Krger N., Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation Leukemia 2007 21 9 1851 1858
23. Bladé J., Rosiol L., Cibeira M. T., Rovira M., Carreras E., Hematopoietic stem cell transplantation for multiple myeloma beyond 2010 Blood 2010 115 18 3655 3663
24. Ringdén O., Karlsson H., Olsson R., Omazic B., Uhlin M., The allogeneic graft-versus-cancer effect British Journal of Haematology 2009 147 5 614 633
25. Maddison P., Thorpe A., Silcocks P., Robertson J. F. R., Chapman C. J., Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer Lung Cancer 2010 70 3 335 339
26. Vural B., Chen L. C., Saip P., Chen Y. T., Ustuner Z., Gonen M., Simpson A. J. G., Old L. J., Ozbek U., Gure A. O., Frequency of SOX group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters Cancer 2005 103 12 2575 2583 (Pubitemid 40800537)